Oneness Biotech , Ltd. (4743.TWO) has a profit margin of -167.08%, below the Healthcare sector average of 17.63%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Oneness Biotech , Ltd. (4743.TWO) currently reports a profit margin of -167.08% as of September 2026. That compares with -1195.52% in the prior-year period — up 86.0% year over year. That is below the Healthcare sector average of 17.63%. Use the charts on this page to explore Oneness Biotech , Ltd.'s profit margin history and peer comparisons.
Oneness Biotech , Ltd.'s profit margin increased from -1195.52% to -167.08% — a 86.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Oneness Biotech , Ltd.'s profit margin of -167.08% is lower than the Healthcare sector average of 17.63%. That is roughly 1047.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Oneness Biotech , Ltd.'s current -167.08% should be judged against Healthcare norms (sector average: 17.63%) and against 4743.TWO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -167.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 17.63%. From there, open related valuation or income-statement pages for Oneness Biotech , Ltd., and consider following 4743.TWO for alerts when major investors trade the stock.